Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedImmune FluMist Capacity Could Reach 20 Mil. Doses For 2004 Season

Executive Summary

MedImmune expects up to a five-fold increase in FluMist vaccine supply for the 2004 influenza season

You may also be interested in...



FluMist Reimbursement Is Ahead Of Plan; TV Ads Will Begin Sept. 29

The initial coverage decisions for the FluMist nasal flu vaccine indicate that MedImmune and Wyeth will be able to maintain the $46 per dose price of the vaccine

FluMist Reimbursement Is Ahead Of Plan; TV Ads Will Begin Sept. 29

The initial coverage decisions for the FluMist nasal flu vaccine indicate that MedImmune and Wyeth will be able to maintain the $46 per dose price of the vaccine

FluMist Arriving Ahead Of Schedule; Could Aid Sales, MedImmune Says

MedImmune has begun shipping the first 500,000 doses of the nasal flu vaccine FluMist

Related Content

UsernamePublicRestriction

Register

PS041741

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel